General Information
Version
5
Revision date
2020-01-09
Product name
EPOGEN
Product Synonyms
Epoetin alpha
Chemical name
Recombinant human erythropoietin
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-800-424-9300, 1-703-527-3887, 1-805-447-7233, 1-805-447-1000
Icons in SDS
Company Information
company name
Amgen Inc
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Emergency Overview Pharmaceutical product intended for clinical and commercial manufacturing purposes only. Product contains epoetin alfa, a recombinant form of erythropoietin. Dosage form contents may pose a health hazard only if exposure occurs to contents, e.g., after spill or leak. Repeated overexposure in manufacturing or from a significant spill may potentially cause effects seen in patients administered the drug such as increased hematocrit and blood pressure. Avoid inhalation, skin contact, eye contact, and ingestion. Does not meet GHS Classification Criteria and therefore is not classified. Classification of the drug substance or mixture (drug product in final form, not applicable)
2.2 Label elements
Does not meet GHS Classification Criteria and therefore is not classified.
Other hazards
No information available
2.1 Classification of the substance or mixture
REGULATION (EC) No 1272/2008 Does not meet GHS Classification Criteria and therefore is not classified.